Replimune said it plans to resubmit its melanoma drug for approval following two earlier rejections. The move follows the departure of Food and Drug Administration Commissioner Marty Makary. Replimune ...
May 29 (Reuters) - Replimune said on Friday it it has reached an agreement with the U.S. Food and Drug Administration to resubmit the marketing application for its experimental skin cancer drug ...
PERTH, March 30 (Reuters) - Woodside Energy (WDS.AX), opens new tab has withdrawn plans for its huge Browse carbon capture and storage (CCS) project from the Australian government's environmental ...
PERTH, Jan 20 (Reuters) - Japan’s Inpex (1605.T), opens new tab will resubmit an environmental plan for its proposed 8 million metric ton-per-year Bonaparte carbon capture and storage (CCS) project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results